AEMETIS ($AMTX) posted quarterly earnings results for Q4 2025 on Thursday, March 12th. The company reported earnings of -$0.24 per share, missing estimates of -$0.22 by $0.02. The company also reported revenue of $43,310,000, missing estimates of $86,985,090 by $-43,675,090.
You can see Quiver Quantitative's $AMTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AEMETIS Hedge Fund Activity
We have seen 31 institutional investors add shares of AEMETIS stock to their portfolio, and 49 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 455,837 shares (+18.4%) to their portfolio in Q4 2025, for an estimated $633,613
- MARSHALL WACE, LLP added 415,978 shares (+289.3%) to their portfolio in Q4 2025, for an estimated $578,209
- MILLENNIUM MANAGEMENT LLC removed 411,723 shares (-77.7%) from their portfolio in Q4 2025, for an estimated $572,294
- RENAISSANCE TECHNOLOGIES LLC removed 363,001 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $504,571
- GOLDMAN SACHS GROUP INC removed 334,894 shares (-77.6%) from their portfolio in Q4 2025, for an estimated $465,502
- 683 CAPITAL MANAGEMENT, LLC added 235,557 shares (+inf%) to their portfolio in Q4 2025, for an estimated $327,424
- HAMILTON CAPITAL PARTNERS, LLC added 200,686 shares (+inf%) to their portfolio in Q4 2025, for an estimated $278,953
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AEMETIS Analyst Ratings
Wall Street analysts have issued reports on $AMTX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Ascendiant Capital issued a "Buy" rating on 11/19/2025
To track analyst ratings and price targets for AEMETIS, check out Quiver Quantitative's $AMTX forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
